# Emtricitabine and Tenofovir Disoproxil Fumarate

NDC: 42543-719
Generic name: EMTRICITABINE and TENOFOVIR Disoproxil Fumarate
Labeler / Manufacturer: Strides Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210330

FDA application: ANDA091055

## Active ingredients

- EMTRICITABINE: 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42543-719"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42543-719
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ecc604c-c4b4-4419-a733-ecb11662fc81